Regulation of the JAK/STAT signaling pathway: The promising targets for cardiovascular disease

Area of Science:

• Cardiovascular Biology
• Molecular Signaling
• Immunology

Background:

• The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is crucial for cellular processes including growth, differentiation, and immune function.
• Animal models reveal JAK/STAT involvement in various cardiovascular conditions such as myocardial ischemia-reperfusion injury, myocardial infarction, hypertension, myocarditis, heart failure, angiogenesis, and fibrosis.
• Growing evidence suggests a significant therapeutic role for JAK/STAT signaling in cardiovascular diseases (CVDs).

Purpose of the Study:

• To review the multifaceted roles of the JAK/STAT pathway in both normal and diseased heart conditions.
• To summarize current findings on JAK/STAT signaling within the context of cardiovascular diseases.
• To discuss the clinical applicability and limitations of targeting JAK/STAT for CVD treatment.

Main Methods:

• Retrospective review of existing literature.
• Analysis of animal model studies on JAK/STAT in cardiovascular pathophysiology.
• Synthesis of current research on JAK/STAT signaling in cardiovascular diseases.

Main Results:

• The JAK/STAT pathway is implicated in fundamental cellular functions relevant to cardiac health.
• JAK/STAT signaling pathways are demonstrably involved in the pathogenesis of numerous cardiovascular conditions.
• The pathway presents potential as a therapeutic target for managing cardiovascular diseases.

Conclusions:

• The JAK/STAT pathway is a key regulator in cardiovascular homeostasis and disease.
• Targeting JAK/STAT signaling offers promising therapeutic avenues for cardiovascular diseases.
• Further research is needed to overcome technical limitations and toxicity concerns for clinical translation.